Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns.
about
Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosisOrigin and proliferation of multiple-drug resistance in bacterial pathogensOutcomes after chemotherapy with WHO category II regimen in a population with high prevalence of drug resistant tuberculosisAre survey-based estimates of the burden of drug resistant TB too low? Insight from a simulation studyDynamics of antibiotic resistant Mycobacterium tuberculosis during long-term infection and antibiotic treatmentRelapse, re-infection and mixed infections in tuberculosis disease.Latent coinfection and the maintenance of strain diversity.Clinical outcomes among persons with pulmonary tuberculosis caused by Mycobacterium tuberculosis isolates with phenotypic heterogeneity in results of drug-susceptibility testsMycobacterium tuberculosis Whole Genome Sequences From Southern India Suggest Novel Resistance Mechanisms and the Need for Region-Specific Diagnostics.Increased level of acute phase reactants in patients infected with modern Mycobacterium tuberculosis genotypes in Mwanza, Tanzania.Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomes.Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, UgandaGlobal control of tuberculosis: from extensively drug-resistant to untreatable tuberculosisEvaluation of the analytical performance of the Xpert MTB/RIF assay.Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment.Molecular detection of mixed infections of Mycobacterium tuberculosis strains in sputum samples from patients in Karonga District, Malawi.Mixed infection with Beijing and non-Beijing strains and drug resistance pattern of Mycobacterium tuberculosis.Long term follow-up of drug resistant and drug susceptible tuberculosis contacts in a Low incidence setting.Mixed-strain Mycobacterium tuberculosis infections among patients dying in a hospital in KwaZulu-Natal, South Africa.Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populationsPrevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study.Population structure of mixed Mycobacterium tuberculosis infection is strain genotype and culture medium dependent.Mixed infection and clonal representativeness of a single sputum sample in tuberculosis patients from a penitentiary hospital in Georgia.Models to understand the population-level impact of mixed strain M. tuberculosis infections.Molecular epidemiology of tuberculosis: current insights.Advanced immune suppression is associated with increased prevalence of mixed-strain Mycobacterium tuberculosis infections among persons at high risk for drug-resistant tuberculosis in BotswanaRecurrence due to relapse or reinfection with Mycobacterium tuberculosis: a whole-genome sequencing approach in a large, population-based cohort with a high HIV infection prevalence and active follow-upMixed infections of Mycobacterium tuberculosis in tuberculosis patients in Shanghai, China.Mixed Infections and Rifampin Heteroresistance among Mycobacterium tuberculosis Clinical Isolates.ClassTR: Classifying Within-Host Heterogeneity Based on Tandem Repeats with Application to Mycobacterium tuberculosis Infections.Genotypic, Phenotypic and Clinical Validation of GeneXpert in Extra-Pulmonary and Pulmonary Tuberculosis in India.Mycobacterium tuberculosis population structure determines the outcome of genetics-based second-line drug resistance testing.Multidrug resistance after inappropriate tuberculosis treatment: a meta-analysisDeep Whole-Genome Sequencing to Detect Mixed Infection of Mycobacterium tuberculosis.Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and controlUpdate in tuberculosis 2005.Drug resistance characteristics and cluster analysis of M. tuberculosis in Chinese patients with multiple episodes of anti-tuberculosis treatmentThe challenge of re-treatment pulmonary tuberculosis at two teaching and referral hospitals in UgandaThe emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guérin (BCG) vaccines: is there a link?Extensively drug resistant tuberculosis in a high income country: a report of four unrelated cases
P2860
Q26824812-6B57B1BF-D449-421A-8598-30E075CCBCAEQ27023284-FFAC9A6D-0D07-4350-B04A-1A078EE018F8Q28471986-78ECBA1A-A249-408F-B399-1501AEA428A8Q28472943-A18BB1CF-7BF9-40A0-8ACB-C8A96FE7C619Q28478602-E1D6462B-03B8-4576-8E52-74D4C42E2C24Q30235139-2451EF10-F100-4C6B-958A-561C52A91A39Q33392974-296A337C-54BE-4E7A-88AF-11B93D8721A0Q33596103-3AD4D3A4-906C-4460-8E4B-4820AF39DE0AQ33696037-89E4D85F-E0B5-49C5-93C7-06F8651EE86FQ33756463-B9FFD865-F2B8-4D4B-994B-9BD466ED21E9Q33900005-79E8FF6F-C24E-4B05-BB50-5F44E1561070Q33904830-DC0BA311-630F-499F-9E02-77EEC9C4FDB5Q33926262-0EADA3A3-FD56-4C41-9009-4F80A1F1CABAQ33963553-0D2BF787-F5CD-4E27-AD46-5EC1E6CC1CD8Q34065647-59300C8C-7785-41F9-9ECD-EF1EE47ECE06Q34433086-CBAAFF69-030B-4A72-86EA-3F3FE9C606A3Q34433199-4D01D872-E56F-429E-A747-5D1274C8820DQ34454109-F26CCD87-4536-488C-9F05-F8BE7880A994Q34487600-D21C38D4-1BF9-4EE8-9744-4D15E62DD2E7Q34598512-C96E174B-1678-4D31-BE08-7D9F4DA434F0Q34707237-69C4711C-CC7F-486A-911D-3C51A2AFEDA8Q34922107-4CE13ABA-2509-4966-BEB0-69CDF5866821Q34974715-E4C81F24-6393-45AF-9F09-21158B564EDAQ35037192-AA1987F6-E603-4FFF-975C-E9A43255CF62Q35070843-92C7BCFA-4D13-4580-93C2-803CBD0E6A6CQ35152791-8F10D256-BA15-4484-899E-AF576641799BQ35163313-A506D578-4B0E-451C-B77C-993E65E2E79CQ35341968-5BF07B85-0F63-4858-BE9B-DFA670FB1183Q35757559-FA95ADCE-7FB9-429F-BA3E-1DEC8EED9758Q35909861-3D47FA59-0009-4688-B07B-1A5F01BECD4EQ35928273-008AE790-A49B-48CF-9D5E-F419367C2710Q35941443-A7508FD6-C2C9-46F5-96A3-C0F9996A16D1Q36001543-F485AFC6-81D1-4F5B-828A-24CFFA64F72FQ36071093-A7673CA3-622C-4C79-AF64-25447C5B1E57Q36361918-BFC04F35-9368-4B42-B80E-1C989AC166CEQ36403165-C7EB130E-8B92-425A-B691-10B87EA0AC67Q36439741-8A0C45B7-D76F-4CB3-A060-313D661D3754Q36500720-07D43599-1096-4774-938C-B9770862BE16Q36565187-F78EBBC2-256C-4A08-8427-802C2F093385Q36700439-7A962E9F-A68E-4C54-9DB4-59F80B603433
P2860
Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 June 2005
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Reinfection and mixed infectio ...... osis drug-resistance patterns.
@en
Reinfection and mixed infectio ...... osis drug-resistance patterns.
@nl
type
label
Reinfection and mixed infectio ...... osis drug-resistance patterns.
@en
Reinfection and mixed infectio ...... osis drug-resistance patterns.
@nl
prefLabel
Reinfection and mixed infectio ...... osis drug-resistance patterns.
@en
Reinfection and mixed infectio ...... osis drug-resistance patterns.
@nl
P2093
P2860
P50
P1476
Reinfection and mixed infectio ...... osis drug-resistance patterns.
@en
P2093
Emma J Murray
Madalene Richardson
Nico C Gey van Pittius
Paul D van Helden
Thomas C Victor
P2860
P304
P356
10.1164/RCCM.200503-449OC
P407
P577
2005-06-09T00:00:00Z